Revised SPCs: Eylea (aflibercept) 40 mg/ml solution for injection – pre-filled syringe and vial

Retinal haemorrhage has been added to SPC as a very common (≥1/10 frequency) adverse effect of treatment.

Source:

electronic Medicines compendium